US Dry Age-Related Macular Degeneration Market and Competitive Landscape - 2018

  • ID: 4630241
  • Report
  • Region: United States
  • Fore Pharma
1 of 3
The latest research US Dry Age-Related Macular Degeneration Market and Competitive Landscape - 2018, provides comprehensive insights into Dry Age-Related Macular Degeneration pipeline, epidemiology, market valuations, product sales, market forecast, product forecasts, and market shares. This study accurately estimates and forecast Dry Age-Related Macular Degeneration market size and drug sales. This research also provides insights into Dry Age-Related Macular Degeneration epidemiology and late stage pipeline.

The research is classified into following sections - Dry Age-Related Macular Degeneration overview with definitions, symptoms, etiology, diagnosis, treatment options; Dry Age-Related Macular Degeneration pipeline insights covering late stage clinical trials pipeline; Dry Age-Related Macular Degeneration prevalence trends by countries; Dry Age-Related Macular Degeneration market size and forecast by countries, market events, trends; product sales and forecast by countries; market shares by countries. The research scope includes the market - USA.

Research Scope:
  • Dry Age-Related Macular Degeneration pipeline: Find out the drugs in clinical trials for Dry Age-Related Macular Degeneration by stages, phase 3 clinical trials, phase 2 clinical trials, and phase 1 clinical trials, by pharmacological class, by company
  • Dry Age-Related Macular Degeneration epidemiology: Find out the prevalence of Dry Age-Related Macular Degeneration in US; prevalence forecast to 2023
  • Dry Age-Related Macular Degeneration products: Identify key products marketed and prescribed for Dry Age-Related Macular Degeneration by brand name, by molecule, by company, by branded / generic, in US
  • Dry Age-Related Macular Degeneration market size: Find out the market size for Dry Age-Related Macular Degeneration drugs in US; Find out how the market advanced from 2014
  • Dry Age-Related Macular Degeneration drug sales: Find out the sales of Dry Age-Related Macular Degeneration drugs in US
  • Dry Age-Related Macular Degeneration drugs sales forecast: Sales forecast for Dry Age-Related Macular Degeneration drugs to 2023 in US
  • Dry Age-Related Macular Degeneration market share analysis: Find out the market shares of Dry Age-Related Macular Degeneration drugs and outlook in US
Benefits of this Research:
  • Evaluate commercial market opportunities for Dry Age-Related Macular Degeneration drugs
  • Synthesize insights for business development & licensing
  • Track market size, competitor drug sales, market shares in Dry Age-Related Macular Degeneration market
  • Develop in-depth knowledge of competition and markets
  • Analyze sales data to update your brand planning trackers
  • Develop tactics and strategies to take advantage of opportunities in the market
  • Track market trends and analyze key events in Dry Age-Related Macular Degeneration market
  • Develop forecast models, healthcare frameworks, or economic models
  • Answer key business questions; supports decision making in R&D to long term marketing strategies


** This report will be delivered within 48 hours after an order is placed.**
READ MORE
Note: Product cover images may vary from those shown
2 of 3
1. Dry Age-Related Macular Degeneration: Disease Overview
1.1. Dry Age-Related Macular Degeneration Symptoms
1.2. Dry Age-Related Macular Degeneration Etiology
1.3. Dry Age-Related Macular Degeneration Diagnosis
1.4. Dry Age-Related Macular Degeneration Treatment Options

2. Dry Age-Related Macular Degeneration Pipeline Insights
2.1. Dry Age-Related Macular Degeneration Phase 3 Clinical Trials
2.2. Dry Age-Related Macular Degeneration Phase 2 Clinical Trials
2.3. Dry Age-Related Macular Degeneration Phase 1 Clinical Trials

3. Dry Age-Related Macular Degeneration Epidemiology Analysis

4. US Dry Age-Related Macular Degeneration Market Insights
4.1. Marketed Products for Dry Age-Related Macular Degeneration in US
4.2. US Dry Age-Related Macular Degeneration Market Size & Forecast
4.3. US Dry Age-Related Macular Degeneration Product Sales Forecast

List of Tables
Table 1: Dry Age-Related Macular Degeneration Phase 3 Clinical Trials, Global, 2018
Table 2: Dry Age-Related Macular Degeneration Phase 2 Clinical Trials, Global, 2018
Table 3: Dry Age-Related Macular Degeneration Phase 1 Clinical Trials, Global, 2018
Table 4: Dry Age-Related Macular Degeneration Prevalence , US, 2017 - 2023
Table 5: Marketed Products for Dry Age-Related Macular Degeneration in US, 2017
Table 6: US Dry Age-Related Macular Degeneration Market Size & Forecast ($mn), 2014 - 2023
Table 7: US Dry Age-Related Macular Degeneration Product Sales ($mn), 2014 - 2023

List of Figures
Figure 1: Dry Age-Related Macular Degeneration Pipeline by Phase (%), Global, 2018
Figure 2: Dry Age-Related Macular Degeneration Prevalence , US, 2017 - 2023
Figure 3: US Dry Age-Related Macular Degeneration Market Size ($mn), 2014 - 2023
Figure 4: US Dry Age-Related Macular Degeneration Product Sales ($mn), 2014 - 2023
Figure 5: US Dry Age-Related Macular Degeneration Market Share by Products (%), 2017
Figure 6: US Dry Age-Related Macular Degeneration Market - Future Market Share (%), 2023
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Order Online - visit: https://www.researchandmarkets.com/reports/4630241
Adroll
adroll